World Orphan Drug Congress (WODC) Europe 2024
August 2024
The World Orphan Drug Congress (WODC) Europe 2024 will be held from 22-25 October in Barcelona. This event brings together stakeholders in the rare disease field to discuss advancements, challenges, and future strategies. It’s a platform for patient advocates, industry experts, and policymakers to exchange ideas and collaborate on improving outcomes for those impacted by rare diseases.
Confirmed speakers representing EURORDIS:
- Virginie Bros-Facer (CEO) – “Opening keynote address: How will the current OMP amendments effect orphan drug development and patient access?” (23 October)
- Virginie Bros-Facer (CEO) – “Keynote Panel: The Rare Disease Action Plan – where are we and how to integrate this from a European to a national level for real impact?” (24 October)
- Avril Daly (President) – “Public-Private partnerships to accelerate development and boost innovation in Rare Diseases” (24 October)
- Matt Bolz-Johnson (Mental Health Lead & Healthcare Advisor) and Kirsten Johnson (Board Member) – “Impact of rare disease on mental health and wellbeing – building understanding of the link and impact of rare and complex diseases on mental health and improving outcomes” (25 October)
Free Passes
Patient advocates can obtain free passes to attend the WODC Europe 2024. For more information and to request a pass, please contact us at eurordis@eurordis.org.